This content is from: Capital Markets

In-house reveal concerns about EU derivatives plans

In-house counsel are concerned about the top-down approach that the Esma could apply to the clearing of OTC derivatives

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial